Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Sigyn Therapeutics Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
SIGY
Over the counter
3841
https://www.sigyntherapeutics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Sigyn Therapeutics Inc
Sigyn Therapeutics to Present at Tomorrow's Emerging Growth Conference
- Mar 5th, 2024 2:00 pm
Sigyn Therapeutics™ to Present at Tomorrow’s Emerging Growth Conference
- Mar 5th, 2024 2:00 pm
Presenting on the Emerging Growth Conference 68 Day 1 on March 6 Register Now
- Mar 5th, 2024 12:00 pm
Sigyn Therapeutics Completes Reverse Stock Split
- Feb 1st, 2024 11:30 pm
Sigyn Therapeutics Announces Reverse Stock Split
- Jan 30th, 2024 1:45 pm
Sigyn Therapeutics Releases Letter to Shareholders
- Jan 4th, 2024 1:00 pm
Sigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial Officer
- Dec 12th, 2023 1:30 pm
Sigyn Therapeutics Reports Third Quarter 2023 Financial Results
- Nov 14th, 2023 10:11 pm
Sigyn Therapeutics™ Discloses PCT Patent Submission to Enhance Chemotherapy Delivery and Reduce Cancer Treatment Toxicity
- Oct 4th, 2023 12:30 pm
Sigyn Therapeutics to Present at Today’s Emerging Growth Conference and Tomorrow at the National Investment Bankers Association Conference
- Sep 6th, 2023 12:00 pm
Sigyn Therapeutics Reports Second Quarter 2023 Financial Results
- Aug 14th, 2023 8:30 pm
OTCQB Venture Virtual Investor Conference: Presentations Now Available for Online Viewing
- Aug 4th, 2023 12:35 pm
OTCQB Venture Virtual Investor Conference Agenda Announced for August 3rd
- Jul 31st, 2023 3:26 pm
Sigyn Therapeutics to Present at the OTCQB Venture Virtual Investor Conference on August 3rd
- Jul 31st, 2023 12:35 pm
Sigyn Therapeutics Discloses “DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES” Patent Submission and Related ImmunePrep™ Trademark Application
- May 17th, 2023 11:00 am
Sigyn Therapeutics Reports First Quarter 2023 Financial Results
- May 16th, 2023 11:30 am
Sigyn Therapeutics™ Announces Appointment of Annette Marleau, Ph.D. as Chief Scientific Officer
- Apr 11th, 2023 12:30 pm
Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K
- Mar 31st, 2023 1:45 pm
Scroll